The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
EDITORIAL
Too little too late for young women with STEMI
EuroIntervention 2016;12:e536-e537 published online e-edition August 2016. DOI: 10.4244/EIJV12I5A91
Yolande Appelman1*, MD, PhD; Ernst E. van der Wall2, MD, PhD
1. Department of Cardiology, VU University Medical Center, Amsterdam, The Netherlands; 2. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
Considerable progress has been made in the treatment of ST-elevation myocardial infarction (STEMI) in the last few decades with the introduction and improvement of reperfusion therapy, in particular of primary percutaneous coronary intervention (PPCI). Although no guideline gender-specific differences exist in the treatment of STEMI patients, there is debate about possible differences in mortality after PPCI in men and women.
As reported in several recent STEMI reviews and meta-analyses, women have a worse baseline clinical profile: they are older and have a higher prevalence of diabetes mellitus (DM), hypertension and dyslipidaemia1,2. Certain risk factors seem to have a ...